Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 33.66B | 26.78B | 33.22B | 27.38B | 19.01B | 11.87B |
Gross Profit | 20.22B | 20.67B | 19.41B | 14.54B | 9.38B | 4.10B |
EBITDA | 19.07B | 18.11B | 18.68B | 16.10B | 10.90B | 5.82B |
Net Income | 9.00B | 8.61B | 9.54B | 9.01B | 6.00B | 1.97B |
Balance Sheet | ||||||
Total Assets | 84.23B | 81.65B | 67.44B | 60.51B | 55.32B | 51.36B |
Cash, Cash Equivalents and Short-Term Investments | 16.23B | 13.47B | 10.06B | 12.37B | 13.33B | 14.44B |
Total Debt | 0.00 | 48.03B | 40.62B | 34.41B | 27.92B | 24.38B |
Total Liabilities | 56.80B | 57.03B | 46.50B | 40.68B | 34.89B | 28.51B |
Stockholders Equity | 25.05B | 22.35B | 19.78B | 18.64B | 19.29B | 21.79B |
Cash Flow | ||||||
Free Cash Flow | 8.47B | 8.83B | 3.49B | 4.09B | 6.15B | 406.46M |
Operating Cash Flow | 16.62B | 16.67B | 13.93B | 12.52B | 11.10B | 3.57B |
Investing Cash Flow | -8.94B | -8.78B | -11.09B | -8.48B | -4.97B | -3.22B |
Financing Cash Flow | -3.83B | -5.02B | -4.79B | -4.93B | -7.35B | 6.29B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $9.69B | 13.03 | 25.76% | 7.72% | 9.99% | 17.81% | |
77 Outperform | $5.36B | 19.39 | 44.27% | 4.34% | -10.13% | -6.82% | |
74 Outperform | $12.64B | 11.73 | 138.69% | 1.52% | 6.41% | 49.58% | |
73 Outperform | $11.80B | 25.29 | 36.66% | 3.71% | -2.56% | -14.94% | |
72 Outperform | $6.20B | 18.55 | 8.90% | ― | 20.82% | 47.79% | |
66 Neutral | €4.04B | 9.14 | 18.29% | 3.44% | 3.84% | -103.41% | |
64 Neutral | $7.71B | 13.50 | -21.27% | ― | 1.92% | 36.07% |